Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions.
STAR Protoc
; 3(3): 101620, 2022 09 16.
Article
in En
| MEDLINE
| ID: mdl-36035798
This protocol describes the generation and characterization of human induced pluripotent stem cells (hiPSCs) from erythroblasts. A key difference with classical protocols is the reprogramming of erythroblasts from a simple blood draw as opposed to fibroblasts/keratinocytes, which requires a biopsy. Moreover, working with erythroblasts ensures that no recombination of the TCR/BCR genes occurs, as opposed to T cells and whole peripheral blood mononuclear cells-based approaches. Last, this approach uses non-integrative episomes ensuring no integration of transgenes into the hiPSCs genome. For complete details on the use and execution of this protocol, please refer to Perriot et al. (2018).
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Induced Pluripotent Stem Cells
Limits:
Humans
Language:
En
Journal:
STAR Protoc
Year:
2022
Type:
Article